Clinical AI developer Aidoc has formed the Diagnostic AI Consortium with 12 major U.S. health systems to establish shared standards for evaluating and governing diagnostic artificial intelligence in clinical settings. The consortium aims to shorten the time from scan to diagnosis while addressing safety, quality, and scalability concerns that have slowed enterprise-wide AI adoption.
The consortium's members and mission
The participating health systems include Advocate Health, Cedars-Sinai Health System, Hartford Healthcare, Houston Methodist, Mercy, Mount Sinai Health System, Northwell Health, Northwestern Medicine, Sutter Health, University of Florida Health, University Hospitals of Cleveland, and WellSpan Health. Aidoc will provide the technical infrastructure through its CARE clinical AI foundation model and aiOS enterprise operating system.
The consortium will focus on three specific objectives: designing AI-enabled diagnostic workflows that prioritize urgent cases and deliver results sooner, measuring impacts on safety and quality across member systems, and developing implementation and governance practices that any health system can adopt.
The tension between speed and safety
"For a long time, the industry treated speed and safety as opposing forces in AI: Silicon Valley's 'move fast and break things' against medicine's 'first, do no harm,'" said Aidoc CEO Elad Walach. "This Consortium is built on the belief that it can be done the right way, guided by two principles: iteratively and together."
Walach added that shared standards across leading health systems "is how we earn the right to scale it, and how we shorten the time from detection to diagnosis for every patient."
A shift toward enterprise-wide diagnostic AI
Health systems are moving beyond isolated AI applications to enterprise-wide diagnostic workflows, according to Aidoc. The consortium draws on the experience of member systems to develop tools "purpose-built for clinical decision-making, rigorously validated in clinical practice," with performance continuously monitored for drift and bias across various patient populations, sites, and scanners.
Diagnostic AI has shown the ability to detect subtle clinical signals across imaging, pathology, and electronic health records that can help clinicians identify disease earlier. The consortium expects to share its initial results in 2027. Health professionals seeking training on these technologies can explore AI for Healthcare applications through dedicated courses.
What one member says about the consortium
"Joining the Diagnostic AI consortium reflects our belief that this next generation of AI in radiology will only reach its full potential through shared expertise and accountability across institutions and the industry," said Dr. Leonardo Kayat Bittencourt, vice chair of innovation at University Hospitals. "No single center, however large or reputable, can capture the diversity of imaging, disease, and clinical context needed to build and deploy models that generalize safely and at the scale the world needs."
Why this matters for healthcare professionals
For clinicians and hospital administrators, the consortium signals that diagnostic AI is moving from experimental single-site projects to standardized multi-site deployments with shared governance. This development means professionals working in radiology, pathology, or clinical decision support should expect more consistent AI tools across different health systems, but also more rigorous monitoring of AI drift and performance. The consortium's results due in 2027 could provide the first large-scale evidence base for what works in diagnostic AI implementation and what doesn't, which may shape purchasing decisions and workflow redesigns at hospitals nationwide.
Your membership also unlocks:
